About B-cell CLL/lymphoma 6 member B protein
B-cell CLL/lymphoma 6 member B protein (BCL6B) is a protein
from Homo sapiens identified by UniProt accession
Q8N143, 479 residues long.
MolForge cross-references it against 0 known binders and
139 disease associations.
Target properties
| Protein name | B-cell CLL/lymphoma 6 member B protein |
| UniProt accession | Q8N143 |
| Gene | BCL6B |
| Organism | Homo sapiens |
| Length | 479 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (139)
Diseases linked to this target (Open Targets).
- hepatocellular carcinoma · score 0.10
- gonorrhea · score 0.08
- neoplasm · score 0.08
- colorectal carcinoma · score 0.07
- lymphocyte percentage of leukocytes · score 0.07
- Blackfan-Diamond anemia · score 0.07
- Okt4 epitope deficiency · score 0.07
- neutrophil percentage of leukocytes · score 0.07
- common variable immunodeficiency · score 0.06
- Chronic mucocutaneous candidosis · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8N143-F1 | alphafold | PREDICTED | 54.33 | — |
Amino-acid sequence (479 residues)
MGSPAAPEGA LGYVREFTRH SSDVLGNLNE LRLRGILTDV TLLVGGQPLR AHKAVLIACS GFFYSIFRGR AGVGVDVLSL PGGPEARGFA PLLDFMYTSR LRLSPATAPA VLAAATYLQM EHVVQACHRF IQASYEPLGI SLRPLEAEPP TPPTAPPPGS PRRSEGHPDP PTESRSCSQG PPSPASPDPK ACNWKKYKYI VLNSQASQAG SLVGERSSGQ PCPQARLPSG DEASSSSSSS SSSSEEGPIP GPQSRLSPTA ATVQFKCGAP ASTPYLLTSQ AQDTSGSPSE RARPLPGSEF FSCQNCEAVA GCSSGLDSLV PGDEDKPYKC QLCRSSFRYK GNLASHRTVH TGEKPYHCSI CGARFNRPAN LKTHSRIHSG EKPYKCETCG SRFVQVAHLR AHVLIHTGEK PYPCPTCGTR FRHLQTLKSH VRIHTGEKPY HCDPCGLHFR HKSQLRLHLR QKHGAATNTK VHYHILGGP
Explore B-cell CLL/lymphoma 6 member B protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets